BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15209698)

  • 21. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
    Landy SH; McGinnis JE; McDonald SA
    Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sumatriptin vs dihydroergotamine: patient preference.
    Tfelt-Hansen P; Steiner TJ
    Int J Clin Pract; 2001 Mar; 55(2):151. PubMed ID: 11321860
    [No Abstract]   [Full Text] [Related]  

  • 25. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
    Cutrer FM; Goadsby PJ; Ferrari MD; Lipton RB; Dodick DW; McCrory D; Williams P
    Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
    Kato K
    No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intranasal zolmitriptan acts quickly].
    Ziegler R
    Med Monatsschr Pharm; 2007 Mar; 30(3):121-2. PubMed ID: 17405495
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J; Diener HC
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
    Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
    Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.
    Velati D; Viana M; Cresta S; Mantegazza P; Testa L; Bettucci D; Rinaldi M; Sances G; Tassorelli C; Nappi G; Canonico PL; Martignoni E; Genazzani AA
    Eur J Pharmacol; 2008 Feb; 580(1-2):43-7. PubMed ID: 18035351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zolmitriptan (Zomig) nasal spray for migraine.
    Med Lett Drugs Ther; 2004 Jan; 46(1174):7-8. PubMed ID: 14726853
    [No Abstract]   [Full Text] [Related]  

  • 37. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cluster headache].
    Nissilä M
    Duodecim; 2009; 125(1):67-72. PubMed ID: 19341028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with intranasal zolmitriptan in cluster headache].
    Pascual J; Navarro A; Caminero AB; Jurado C
    Neurologia; 2006 Apr; 21(3):131-4. PubMed ID: 16575626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.